ReviewTranslational cancer research2020

CRISPR-Cas genome editing tool: a narrow lane of cancer therapeutics with potential blockades.

Devyani Bhatkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.